Caris Life Sciences Adds 500 Jobs and Space With Corporate Park in Irving

Caris Life Sciences is expanding in Irving, adding 115,000 square feet of research and development and office space while creating 500 new job opportunities. Caris Life Sciences Park will allow the company to expand beyond their work in blood-based diagnostics and molecular profiling. The new facility’s first phase should be complete in early 2020, and will include future laboratories and corporate office space. The last two phases will include additional lab space for the molecular science innovators. “Our new facilities in Irving, Texas will allow us to add to our team of experts, and enhance our ability to deliver more… Full Story

The University of Puerto Rico Added to Caris Life Sciences Alliance

Caris Life Sciences has just announced that the University of Puerto Rico will be inducted into their Precision Oncology Alliance (POA), making UPR the 28th member. Powered by the molecular science company, the POA is a network of cancer centers working to improve standards of care and practices for the application of molecular profiling in cancer treatment. UPR serves 85 percent of Puerto Rico’s cancer patients and participates in medical research, molecular science, and the development of new drugs and treatments. UPR consists of the UPR Hospital at Carolina, Ambulatory Clinic of UPR, Puerto Rico Medical Center in San Juan,… Full Story

Caris Life Sciences Adds Industry Veteran to its Advisory Board

Dr. Steven D. Averbuch will bring more than three decades of oncology drug experience to Caris Life Sciences’ Scientific Advisory Board after retiring as Vice President and Head of Precision Medicine at Bristol-Myers Squibb. The board is a group of cancer researchers, bioinformaticians and clinical oncologists who help guide and accelerate the work Caris does in improving precision cancer care. Averbuch has been a part of several drug and companion diagnostic approvals in major markets, and recently retired from BMS where he led integrated biomarker and pharmacodiagnostic work in research and development. Averbuch also had leadership roles at Merck Research Laboratories,… Full Story

Caris Life Sciences Adds Florida Cancer Center to its Oncology Alliance

Irving-based Caris Life Sciences will be adding a 26th cancer center to its Precision Oncology Alliance when the Sylvester Comprehensive Cancer Center at the Miami Miller School of Medicine joins the group. The alliance is a network of cancer centers that work together to develop standards of care and best practices to improve cancer treatment. Caris Life Sciences is a biotechnology company that addresses cancer and other diseases through several platforms that inform drug development and other treatment. The Precision Oncology Alliance helps lead the development of precision cancer care, and the Miami center will add to the alliance’s collection of… Full Story